LMAT
NASDAQ · Health Care
Lemaitre Vascular Inc
$93.95
+1.74 (+1.89%)
Financial Highlights (FY 2026)
Revenue
253.44M
Net Income
58.62M
Gross Margin
71.5%
Profit Margin
23.1%
Rev Growth
+15.6%
D/E Ratio
0.43
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 71.5% | 71.5% | 55.1% | 55.1% |
| Operating Margin | 27.2% | 24.5% | 15.7% | 15.2% |
| Profit Margin | 23.1% | 22.0% | 12.7% | 14.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 253.44M | 219.30M | 688.78M | 823.96M |
| Gross Profit | 181.29M | 156.87M | 379.66M | 454.17M |
| Operating Income | 68.96M | 53.70M | 108.14M | 124.98M |
| Net Income | 58.62M | 45.65M | 87.65M | 120.31M |
| Gross Margin | 71.5% | 71.5% | 55.1% | 55.1% |
| Operating Margin | 27.2% | 24.5% | 15.7% | 15.2% |
| Profit Margin | 23.1% | 22.0% | 12.7% | 14.6% |
| Rev Growth | +15.6% | +15.6% | +17.5% | -8.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 322.04M | 322.04M | 832.61M | 742.63M |
| Total Equity | 751.37M | 751.37M | 1.10B | 1.03B |
| D/E Ratio | 0.43 | 0.43 | 0.76 | 0.72 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 74.69M | 61.39M | 151.37M | 185.12M |
| Free Cash Flow | — | — | 80.37M | 83.71M |